• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: Results of a national vaccination campaign

tetano

Editor, Senior Moderator
Vaccine. 2010 Oct 8. [Epub ahead of print]
Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: Results of a national vaccination campaign.

Bone A, Guthmann JP, Nicolau J, L?vy-Bruhl D.

Institut de Veille Sanitaire (French Institute for Public Health Surveillance), 12 rue du Val d'Osne, 94415 Saint-Maurice Cedex, France; EPIET European Programme for Intervention Epidemiology, European Centre for Disease Control (ECDC), Stockholm, Sweden.
Abstract

A mass vaccination campaign against influenza A/H1N1 was launched in France in October 2009. Vaccination was offered free of charge to the entire population according to a pre-defined order of priority. Demographic data and data on vaccinations given were recorded in a dedicated database. We analysed vaccine uptake by age, sex and region in the overall population and in certain risk groups, including pregnant women. Overall vaccine uptake was 8% and varied by age-group and sex. Vaccine uptake in pregnant women was 22.7%. These low uptakes may reflect controversies around the vaccine and vaccination policy and have important implications for future pandemic vaccination strategies.

PMID: 20937310 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20937310
 
Back
Top Bottom